Global End-Stage Renal Disease (ESRD) Market Insights

The End Stage Renal Disease (ESRD) Drug Global Market Report 2023, provides comprehensive information on the end stage renal disease (ESRD) drug market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The End Stage Renal Disease (ESRD) Drug Market’s Growth:

https://www.thebusinessresearchcompany.com/report/end-stage-renal-disease-esrd-drug-global-market-report

As per The Business Research Company’s End Stage Renal Disease (ESRD) Drug Global Market Report 2023, the global end stage renal disease (ESRD) drug market size is expected to grow from $101.73 billion in 2022 to $115.82 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global end stage renal disease (ESRD) drug market size is expected to grow to $193.98 billion in 2027 at a CAGR of 13.8%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9437&type=smp

Product innovations are a key trend in gaining popularity in the end-stage renal disease (ESRD) drug market. Major companies operating in the end-stage renal disease (ESRD) drug market are focused on developing innovative solutions to sustain in the market. For instance, in April 2022, GlaxoSmithKline Plc, a UK-based pharmaceutical and biotechnology firm, announced that the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for the possible treatment of patients with chronic kidney disease anaemia (CKD). The new product is based on the unique nobel prize-winning science that proved how cells sense and adapt to oxygen availability.

The end stage renal disease (ESRD) drug market is segmented:

1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products

2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkalaemia

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

North America was the largest region in the end stage renal disease (ESRD) drug market in 2022.

The table of contents in TBRC’s end stage renal disease (ESRD) drug market report includes:

1. Executive Summary
2. End Stage Renal Disease (ESRD) Drug Market Characteristics
3. End Stage Renal Disease (ESRD) Drug Market Trends And Strategies
4. End Stage Renal Disease (ESRD) Drug Market – Macro Economic Scenario
5. End Stage Renal Disease (ESRD) Drug Market Size And Growth

.

.

.

26. Africa End Stage Renal Disease (ESRD) Drug Market
27. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The End Stage Renal Disease (ESRD) Drug Market
29. End Stage Renal Disease (ESRD) Drug Market Future Outlook and Potential Analysis
30. Appendix

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model